BioSpace News Archive

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (“CRH” or the “Company”), today announced the appointment of Dr. Tushar Ramani as CEO of the Company, replacing outgoing CEO Edward Wright.

Immunicom’s Chairman, David Schlotterbeck, the former Vice Chairman of Cardinal Health and CEO/Chairman of CareFusion, delivered the keynote address and Immunicom’s Chief Commercial Officer, Stephen Prince, presented independently on Immunicom’s technology, commercial strategy, global clinical trials, future products pipeline, and revenue projections.

Verrix, developer of solutions for rapid and accurate sterilization confirmation, is expanding its leadership team in preparation for commercialization of its EVA™ Biological Indicator (BI) System.

Insiders Provide Real Solutions to the Tough Problems Plaguing the Industry

Combating misconceptions surrounding the field of regenerative medicine and the use of stem cells, industry leader Liveyon, LLC’s latest video podcast took a deep dive into the subject of hair restoration.

Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.

Health simulation company Kognito today announced a new professional development role-play simulation that prepares K-12 school personnel to respond to a death in the school community.

NewYork-Presbyterian, in collaboration with physicians from Columbia University Irving Medical Center, has launched a state-of-the-art sports medicine and performance training facility in Westchester County that gives patients and athletes access to some of the nation’s top sports medicine doctors, therapists, and elite sports performance coaches–all at a single location.

The Roskamp Institute is pleased to announce that its third-annual signature event, Grey Matters—A Symposium on Alzheimer’s Disease Research, is half sold after registration opening only a few weeks ago.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that the company has secured 100 new retail locations in Q1 2019, significantly outpacing its growth forecast for that time period.